U.S. NeuroSurgical Holdings, Inc.
USNU · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | -$0 | -$0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | -100% | – |
| Gross Profit | -$0 | -$0 | -$0 | $0 |
| % Margin | – | – | – | 91.9% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | -48.5% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | -83% |
| EPS Diluted | -0.13 | -0.088 | -0.17 | -0.11 |
| % Growth | -47.9% | 48.3% | -54.5% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | $0 |
| Capital Expenditures | $0 | $0 | -$0 | $0 |
| Free Cash Flow | -$0 | -$0 | -$0 | $0 |